Thabo Mahendiran

机构：Centre Hospitalier Universitaire Vaudois, Onze Lieve Vrouwziekenhuis Hospital, Hôpital Orthopédique de la Suisse Romande, Al-Azhar University, Flanders Environment Agency, University of Lausanne · ORCID：0000-0002-0025-8162

发表论文 93 篇 · 总被引 869 次 · h-index 15

代表论文

• Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trial (2026 · Nature Medicine · 被引 12)
• The Elusiveness of “Rest”: The Challenges of Assessing Resting Coronary Physiology (2025 · Circulation · 被引 6)
• Vessel‐Specific Myocardial Mass in Patients With Stable Coronary Artery Disease (2025 · Journal of the American Heart Association · 被引 5)
• Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow (2026 · JACC: Cardiovascular Interventions · 被引 3)
• Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction (2025 · EuroIntervention · 被引 3)
• Coronary autoregulation: the complex interplay between epicardial and microvascular resistance (2026 · European Heart Journal · 被引 2)